Where can I find more information about this study?
The detailed title for this research study is:
A Phase 3b, Controlled, Open-Label, Multi-Center Study to Evaluate Safety and Immunogenicity of a Single
Dose of GlaxoSmithKlineâ€™s Meningococcal ACWY Conjugate Vaccine (Menveo), Administered to Healthy
Individuals 15 through 55 years of age, approximately 4-6 years after primary ACWY vaccination.
Clinical studies have unique study numbers. Below are the unique study numbers associated with this
study.
Organization Website Study Number
European Medicines Agency www.clinicaltrialsregister.eu 2016-003186-25
United States National Institutes of Health (NIH) www.clinicaltrials.gov NCT02986854
Your doctor can help you understand more about this study and the results. You should not make
changes to your care based on the results of this or any single study.
This document was developed and approved by GSK on 12 March 2019. The information in this summary
does not include additional information available after this date.
For readers of this document in text form, the websites associated with the hyperlinks above are:
EudraCT summary:
https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003186-25/results
US NIH/clinicaltrials.gov:
https://clinicaltrials.gov/ct2/show/NCT02986854